<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38843304</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>Temporal regulation of MDA5 inactivation by Caspase-3 dependent cleavage of 14-3-3η.</ArticleTitle><Pagination><StartPage>e1012287</StartPage><MedlinePgn>e1012287</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1012287</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1012287</ELocationID><Abstract><AbstractText>The kinetics of type I interferon (IFN) induction versus the virus replication compete, and the result of the competition determines the outcome of the infection. Chaperone proteins that involved in promoting the activation kinetics of PRRs rapidly trigger antiviral innate immunity. We have previously shown that prior to the interaction with MAVS to induce type I IFN, 14-3-3η facilitates the oligomerization and intracellular redistribution of activated MDA5. Here we report that the cleavage of 14-3-3η upon MDA5 activation, and we identified Caspase-3 activated by MDA5-dependent signaling was essential to produce sub-14-3-3η lacking the C-terminal helix (αI) and tail. The cleaved form of 14-3-3η (sub-14-3-3η) could strongly interact with MDA5 but could not support MDA5-dependent type I IFN induction, indicating the opposite functions between the full-length 14-3-3η and sub-14-3-3η. During human coronavirus or enterovirus infections, the accumulation of sub-14-3-3η was observed along with the activation of Caspase-3, suggesting that RNA viruses may antagonize 14-3-3η by promoting the formation of sub-14-3-3η to impair antiviral innate immunity. In conclusion, sub-14-3-3η, which could not promote MDA5 activation, may serve as a negative feedback to return to homeostasis to prevent excessive type I IFN production and unnecessary inflammation.</AbstractText><CopyrightInformation>Copyright: © 2024 Chan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yun-Jui</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Nien-Tzu</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsin</LastName><ForeName>Fu</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jia-Ying</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jing-Yi</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Helene Minyi</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-4837-5373</Identifier><AffiliationInfo><Affiliation>Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048948">14-3-3 Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505407">CASP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048948" MajorTopicYN="Y">14-3-3 Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="Y">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="Y">Caspase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>19</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>6</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38843304</ArticleId><ArticleId IdType="pmc">PMC11185488</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1012287</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-24-00024</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Breiman A, Grandvaux N, Lin R, Ottone C, Akira S, Yoneyama M, et al.. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. Journal of virology. 2005;79(7):3969–78. Epub 2005/03/16. doi: 10.1128/JVI.79.7.3969-3978.2005 [pii] ; PubMed Central PMCID: PMC1061556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.3969-3978.2005</ArticleId><ArticleId IdType="pmc">PMC1061556</ArticleId><ArticleId IdType="pubmed">15767399</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, et al.. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(2):582–7. doi: 10.1073/pnas.0606699104 ; PubMed Central PMCID: PMC1766428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606699104</ArticleId><ArticleId IdType="pmc">PMC1766428</ArticleId><ArticleId IdType="pubmed">17190814</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al.. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol. 2005;6(10):981–8. Epub 2005/08/30. doi: 10.1038/ni1243 [pii] .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1243</ArticleId><ArticleId IdType="pubmed">16127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, et al.. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(15):6001–6. Epub 2006/04/06. doi: 10.1073/pnas.0601523103 [pii] ; PubMed Central PMCID: PMC1458687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0601523103</ArticleId><ArticleId IdType="pmc">PMC1458687</ArticleId><ArticleId IdType="pubmed">16585524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J-P, Fan Y-K, Liu HM. The 14-3-3η chaperone protein promotes antiviral innate immunity via facilitating MDA5 oligomerization and intracellular redistribution. PLoS pathogens. 2019;15(2):e1007582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386420</ArticleId><ArticleId IdType="pubmed">30742689</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(35):14590–5. Epub 2011/08/17. doi: 10.1073/pnas.1110133108 [pii] ; PubMed Central PMCID: PMC3167523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110133108</ArticleId><ArticleId IdType="pmc">PMC3167523</ArticleId><ArticleId IdType="pubmed">21844353</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu HM, Loo YM, Horner SM, Zornetzer GA, Katze MG, Gale M, Jr. The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe. 2012;11(5):528–37. doi: 10.1016/j.chom.2012.04.006 ; PubMed Central PMCID: PMC3358705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.04.006</ArticleId><ArticleId IdType="pmc">PMC3358705</ArticleId><ArticleId IdType="pubmed">22607805</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al.. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. Journal of virology. 2008;82(1):335–45. doi: 10.1128/JVI.01080-07 ; PubMed Central PMCID: PMC2224404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01080-07</ArticleId><ArticleId IdType="pmc">PMC2224404</ArticleId><ArticleId IdType="pubmed">17942531</ArticleId></ArticleIdList></Reference><Reference><Citation>Errett JS, Suthar MS, McMillan A, Diamond MS, Gale M, Jr. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. Journal of virology. 2013;87(21):11416–25. doi: 10.1128/JVI.01488-13 ; PubMed Central PMCID: PMC3807316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01488-13</ArticleId><ArticleId IdType="pmc">PMC3807316</ArticleId><ArticleId IdType="pubmed">23966395</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, et al.. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell. 2013;152(1–2):276–89. Epub 2013/01/01. doi: 10.1016/j.cell.2012.11.048 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.11.048</ArticleId><ArticleId IdType="pubmed">23273991</ArticleId></ArticleIdList></Reference><Reference><Citation>Malmgaard L. Induction and regulation of IFNs during viral infections. Journal of interferon &amp; cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2004;24(8):439–54. Epub 2004/08/24. doi: 10.1089/1079990041689665 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/1079990041689665</ArticleId><ArticleId IdType="pubmed">15320958</ArticleId></ArticleIdList></Reference><Reference><Citation>Onomoto K, Onoguchi K, Yoneyama M. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol Immunol. 2021;18(3):539–55. doi: 10.1038/s41423-020-00602-7 ; PubMed Central PMCID: PMC7812568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00602-7</ArticleId><ArticleId IdType="pmc">PMC7812568</ArticleId><ArticleId IdType="pubmed">33462384</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JM, Greten FR, Wong A, Westrick RJ, Arthur JSC, Otsu K, et al.. Signaling Pathways and Genes that Inhibit Pathogen-Induced Macrophage Apoptosis—CREB and NF-κB as Key Regulators. Immunity. 2005;23(3):319–29. doi: 10.1016/j.immuni.2005.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2005.08.010</ArticleId><ArticleId IdType="pubmed">16169504</ArticleId></ArticleIdList></Reference><Reference><Citation>Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al.. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell. 2007;130(5):918–31. doi: 10.1016/j.cell.2007.07.009 ; PubMed Central PMCID: PMC2134986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.07.009</ArticleId><ArticleId IdType="pmc">PMC2134986</ArticleId><ArticleId IdType="pubmed">17803913</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang SY, Yang CH, Chou CC, Chiang YP, Chuang TH, Hsu LC. TLR-induced PAI-2 expression suppresses IL-1beta processing via increasing autophagy and NLRP3 degradation. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(40):16079–84. doi: 10.1073/pnas.1306556110 ; PubMed Central PMCID: PMC3791747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1306556110</ArticleId><ArticleId IdType="pmc">PMC3791747</ArticleId><ArticleId IdType="pubmed">24043792</ArticleId></ArticleIdList></Reference><Reference><Citation>Besch R, Poeck H, Hohenauer T, Senft D, Hacker G, Berking C, et al.. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. J Clin Invest. 2009;119(8):2399–411. doi: 10.1172/JCI37155 ; PubMed Central PMCID: PMC2719920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI37155</ArticleId><ArticleId IdType="pmc">PMC2719920</ArticleId><ArticleId IdType="pubmed">19620789</ArticleId></ArticleIdList></Reference><Reference><Citation>Julien O, Wells JA. Caspases and their substrates. Cell Death Differ. 2017;24(8):1380–9. Epub 2017/05/13. doi: 10.1038/cdd.2017.44 ; PubMed Central PMCID: PMC5520456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.44</ArticleId><ArticleId IdType="pmc">PMC5520456</ArticleId><ArticleId IdType="pubmed">28498362</ArticleId></ArticleIdList></Reference><Reference><Citation>Rongvaux A, Jackson R, Harman CC, Li T, West AP, de Zoete MR, et al.. Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell. 2014;159(7):1563–77. Epub 2014/12/20. doi: 10.1016/j.cell.2014.11.037 ; PubMed Central PMCID: PMC4272443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.11.037</ArticleId><ArticleId IdType="pmc">PMC4272443</ArticleId><ArticleId IdType="pubmed">25525875</ArticleId></ArticleIdList></Reference><Reference><Citation>White MJ, McArthur K, Metcalf D, Lane RM, Cambier JC, Herold MJ, et al.. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell. 2014;159(7):1549–62. doi: 10.1016/j.cell.2014.11.036 ; PubMed Central PMCID: PMC4520319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.11.036</ArticleId><ArticleId IdType="pmc">PMC4520319</ArticleId><ArticleId IdType="pubmed">25525874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning X, Wang Y, Jing M, Sha M, Lv M, Gao P, et al.. Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3. Mol Cell. 2019;74(1):19–31 e7. doi: 10.1016/j.molcel.2019.02.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.02.013</ArticleId><ArticleId IdType="pubmed">30878284</ArticleId></ArticleIdList></Reference><Reference><Citation>El Maadidi S, Faletti L, Berg B, Wenzl C, Wieland K, Chen ZJ, et al.. A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis. J Immunol. 2014;192(3):1171–83. doi: 10.4049/jimmunol.1300842 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300842</ArticleId><ArticleId IdType="pubmed">24391214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kung SH, Hsu YY, Liu WT. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. The Journal of general virology. 2002;83(Pt 6):1367–76. doi: 10.1099/0022-1317-83-6-1367 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-83-6-1367</ArticleId><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, et al.. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 2002;293(2):386–95. doi: 10.1006/viro.2001.1310 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1310</ArticleId><ArticleId IdType="pubmed">11886259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardino AK, Smerdon SJ, Yaffe MB. Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms. Semin Cancer Biol. 2006;16(3):173–82. Epub 2006/05/09. doi: 10.1016/j.semcancer.2006.03.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2006.03.007</ArticleId><ArticleId IdType="pubmed">16678437</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R. Crystal structure of the zeta isoform of the 14-3-3 protein. Nature. 1995;376(6536):191–4. Epub 1995/07/13. doi: 10.1038/376191a0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/376191a0</ArticleId><ArticleId IdType="pubmed">7603574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Lee WH, Sobott F, Papagrigoriou E, Robinson CV, Grossmann JG, et al.. Structural basis for protein-protein interactions in the 14-3-3 protein family. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(46):17237–42. Epub 2006/11/07. doi: 10.1073/pnas.0605779103 ; PubMed Central PMCID: PMC1859916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605779103</ArticleId><ArticleId IdType="pmc">PMC1859916</ArticleId><ArticleId IdType="pubmed">17085597</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A, et al.. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature. 1995;376(6536):188–91. Epub 1995/07/13. doi: 10.1038/376188a0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/376188a0</ArticleId><ArticleId IdType="pubmed">7603573</ArticleId></ArticleIdList></Reference><Reference><Citation>Won J, Kim DY, La M, Kim D, Meadows GG, Joe CO. Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. J Biol Chem. 2003;278(21):19347–51. Epub 2003/03/27. doi: 10.1074/jbc.M213098200 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M213098200</ArticleId><ArticleId IdType="pubmed">12657644</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong AB, Masters SC, Yang H, Fu H. Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins. 2002;49(3):321–5. Epub 2002/10/03. doi: 10.1002/prot.10210 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.10210</ArticleId><ArticleId IdType="pubmed">12360521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan YK, Gack MU. A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol. 2016;17(5):523–30. doi: 10.1038/ni.3393 ; PubMed Central PMCID: PMC4837045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3393</ArticleId><ArticleId IdType="pmc">PMC4837045</ArticleId><ArticleId IdType="pubmed">26998762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Cui Y, Lei H, Cao D, Tang G, Huang H, et al.. Diagnostic accuracy of 14-3-3 eta protein in rheumatoid arthritis: A meta-analysis. Int J Rheum Dis. 2020;23(11):1443–51. doi: 10.1111/1756-185X.13921 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13921</ArticleId><ArticleId IdType="pmc">PMC7756802</ArticleId><ArticleId IdType="pubmed">32909672</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu SC, Imai K, Sawasaki T, Tomii K. ScreenCap3: Improving prediction of caspase-3 cleavage sites using experimentally verified noncleavage sites. Proteomics. 2014;14(17–18):2042–6. doi: 10.1002/pmic.201400002 ; PubMed Central PMCID: PMC4282780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201400002</ArticleId><ArticleId IdType="pmc">PMC4282780</ArticleId><ArticleId IdType="pubmed">24995852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zust R, Cervantes-Barragan L, Habjan M, Maier R, Neuman BW, Ziebuhr J, et al.. Ribose 2’-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol. 2011;12(2):137–43. doi: 10.1038/ni.1979 ; PubMed Central PMCID: PMC3182538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1979</ArticleId><ArticleId IdType="pmc">PMC3182538</ArticleId><ArticleId IdType="pubmed">21217758</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum A, Sachidanandam R, Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(37):16303–8. doi: 10.1073/pnas.1005077107 ; PubMed Central PMCID: PMC2941304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1005077107</ArticleId><ArticleId IdType="pmc">PMC2941304</ArticleId><ArticleId IdType="pubmed">20805493</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nature reviews Immunology. 2020;20(9):537–51. Epub 2020/03/24. doi: 10.1038/s41577-020-0288-3 ; PubMed Central PMCID: PMC7094958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId><ArticleId IdType="pmc">PMC7094958</ArticleId><ArticleId IdType="pubmed">32203325</ArticleId></ArticleIdList></Reference><Reference><Citation>Berke IC, Modis Y. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J. 2012;31(7):1714–26. Epub 2012/02/09. doi: 10.1038/emboj.2012.19 ; PubMed Central PMCID: PMC3321199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.19</ArticleId><ArticleId IdType="pmc">PMC3321199</ArticleId><ArticleId IdType="pubmed">22314235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhir A, Dhir S, Borowski LS, Jimenez L, Teitell M, Rotig A, et al.. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature. 2018;560(7717):238–42. Epub 20180725. doi: 10.1038/s41586-018-0363-0 ; PubMed Central PMCID: PMC6570621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0363-0</ArticleId><ArticleId IdType="pmc">PMC6570621</ArticleId><ArticleId IdType="pubmed">30046113</ArticleId></ArticleIdList></Reference><Reference><Citation>de Cubas AA, Dunker W, Zaninovich A, Hongo RA, Bhatia A, Panda A, et al.. DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. JCI Insight. 2020;5(11). Epub 20200604. doi: 10.1172/jci.insight.137569 ; PubMed Central PMCID: PMC7308050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.137569</ArticleId><ArticleId IdType="pmc">PMC7308050</ArticleId><ArticleId IdType="pubmed">32493845</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ E, Mikhalkevich N, Iordanskiy S. Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response. Microbiol Spectr. 2023;11(2):e0443822. Epub 20230302. doi: 10.1128/spectrum.04438-22 ; PubMed Central PMCID: PMC10100713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.04438-22</ArticleId><ArticleId IdType="pmc">PMC10100713</ArticleId><ArticleId IdType="pubmed">36861980</ArticleId></ArticleIdList></Reference><Reference><Citation>Sluchanko NN, Gusev NB. Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins. FEBS J. 2017;284(9):1279–95. Epub 2016/12/16. doi: 10.1111/febs.13986 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13986</ArticleId><ArticleId IdType="pubmed">27973707</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews DDT, Vlok M, Akbari Bani D, Hay BN, Mohamud Y, Foster LJ, et al.. Cleavage of 14-3-3epsilon by the enteroviral 3C protease dampens RIG-I-mediated antiviral signaling. J Virol. 2023:e0060423. doi: 10.1128/jvi.00604-23 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00604-23</ArticleId><ArticleId IdType="pmc">PMC10506458</ArticleId><ArticleId IdType="pubmed">37555661</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedl W, Acharya D, Lee JH, Liu G, Serman T, Chiang C, et al.. Zika Virus NS3 Mimics a Cellular 14-3-3-Binding Motif to Antagonize RIG-I- and MDA5-Mediated Innate Immunity. Cell Host Microbe. 2019;26(4):493–503 e6. doi: 10.1016/j.chom.2019.09.012 ; PubMed Central PMCID: PMC6922055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.09.012</ArticleId><ArticleId IdType="pmc">PMC6922055</ArticleId><ArticleId IdType="pubmed">31600501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One. 2013;8(5):e63431. doi: 10.1371/journal.pone.0063431 ; PubMed Central PMCID: PMC3641126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pmc">PMC3641126</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sears N, Sen GC, Stark GR, Chattopadhyay S. Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation. J Biol Chem. 2011;286(38):33037–44. Epub 20110804. doi: 10.1074/jbc.M111.257022 ; PubMed Central PMCID: PMC3190878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.257022</ArticleId><ArticleId IdType="pmc">PMC3190878</ArticleId><ArticleId IdType="pubmed">21816816</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SY, Waheed AA, Zhang ZR, Freed EO, Bonifacino JS. HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor. J Biol Chem. 2014;289(51):35102–10. Epub 20141028. doi: 10.1074/jbc.M114.597062 ; PubMed Central PMCID: PMC4271200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.597062</ArticleId><ArticleId IdType="pmc">PMC4271200</ArticleId><ArticleId IdType="pubmed">25352594</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajput A, Kovalenko A, Bogdanov K, Yang SH, Kang TB, Kim JC, et al.. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity. 2011;34(3):340–51. doi: 10.1016/j.immuni.2010.12.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.12.018</ArticleId><ArticleId IdType="pubmed">21419663</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>